1000 Participants Needed

Community-based Psychological Services for Mental Health

(RECOUP-NY Trial)

AB
MS
Overseen ByManaswi Sangraula, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: George Washington University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This trial aims to improve mental health and COVID-19 prevention behaviors among minority and vulnerable groups in New York City by training community workers to provide basic mental health support using Problem Management Plus (PM+).

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Problem Management Plus (PM+) for mental health?

Research shows that Problem Management Plus (PM+) is effective in reducing psychological distress in various settings, including earthquake-affected communities in Nepal and conflict-affected women in Pakistan. It is a low-intensity treatment that can be delivered by non-specialists, making it accessible and practical for communities with limited mental health resources.12345

Is community-based psychological treatment generally safe for humans?

Research shows that adverse events (unwanted effects) can occur in psychotherapy, affecting more than one in ten participants, with serious events in more than one in 21 participants. However, the way these events are recorded and reported varies, making it hard to compare results across studies.678910

How is the treatment Problem Management Plus (PM+) different from other mental health treatments?

Problem Management Plus (PM+) is unique because it is a brief, five-session psychological treatment that can be delivered by non-specialists, making it accessible in low-resource settings. It is designed to help people in communities affected by adversity, such as natural disasters or conflict, and has been adapted for various cultural contexts, demonstrating its flexibility and effectiveness in diverse environments.13111213

Research Team

BK

Brandon A Kohrt, MD

Principal Investigator

George Washington University

Eligibility Criteria

This trial is for individuals in New York City who are experiencing depression, anxiety, or other psychological distress after SARS-CoV-2. Participants should have a certain score on a health questionnaire and be struggling with daily activities due to their mental state. People at acute suicide risk or without functional impairment cannot join.

Inclusion Criteria

My mental health issues are affecting my daily activities.
Persons with Patient Health Questionnaire 4 scores equal to or above 3

Exclusion Criteria

Acute suicide risk
Patient Health Questionnaire 4 score below 3
I do not have any disabilities that affect my daily activities.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive mental health services through community-based organizations, including Problem Management Plus for those in the intervention arm

20 weeks

Follow-up

Participants are monitored for mental health outcomes and adherence to SARS-CoV-2 prevention behaviors

4 weeks

Treatment Details

Interventions

  • Problem Management Plus
  • Services as Usual
Trial Overview The study tests 'Problem Management Plus', a mental health service, against the usual services provided. It aims to see if this can improve behaviors related to preventing SARS-CoV-2 spread, vaccination uptake, and safe healthcare use among minority and vulnerable groups.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Problem Management PlusExperimental Treatment1 Intervention
Persons screening positive for depression will be offered Problem Management Plus delivered by community based organization staff.
Group II: Services as usualActive Control1 Intervention
Persons screening positive for depression will be referred from community-based organizations. The referrals will be made to mental health specialists who will provide care based on their standard of care.

Problem Management Plus is already approved in United States for the following indications:

🇺🇸
Approved in United States as Problem Management Plus for:
  • Post-traumatic stress disorder
  • Anxiety
  • Depression
  • Psychological distress related to COVID-19

Find a Clinic Near You

Who Is Running the Clinical Trial?

George Washington University

Lead Sponsor

Trials
263
Recruited
476,000+

The New School

Collaborator

Trials
5
Recruited
1,400+

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+

Human Sciences Research Council

Collaborator

Trials
12
Recruited
33,400+

Findings from Research

Problem Management Plus (PM+) is an effective low-intensity psychological intervention that can be delivered by nonspecialists to help people with common mental health issues, especially in challenging situations.
The adaptation of PM+ for use in Rwanda, Peru, Mexico, and Malawi highlights the importance of tailoring psychological interventions to fit local contexts while preserving their core elements, which is crucial for successful implementation in public health settings.
Adapting Problem Management Plus for Implementation: Lessons Learned from Public Sector Settings Across Rwanda, Peru, Mexico and Malawi.Coleman, SF., Mukasakindi, H., Rose, AL., et al.[2022]
Problem Based Method groups (PBM) can effectively reduce symptoms of anxiety and depression in individuals on sick leave, but Cognitive Behavioral Therapy (CBT) is more effective overall in addressing mental health issues.
In terms of work ability, CBT demonstrated superior results compared to PBM, significantly improving more aspects of work ability, although both methods showed some positive effects.
Problem-based self-care groups versus cognitive behavioural therapy for persons on sick leave due to common mental disorders: a randomised controlled study.Jansson, I., Gunnarsson, AB., Björklund, A., et al.[2021]
The Group PM+ intervention, a brief psychological support program, was found to be feasible and acceptable for delivery by local non-specialists in an earthquake-affected region of rural Nepal, with 121 participants (83% women) showing good attendance and engagement.
While the study was not designed to measure effectiveness, preliminary results indicated that participants receiving Group PM+ experienced greater improvements in depression symptoms compared to those receiving enhanced usual care, suggesting potential benefits that warrant further investigation in a larger trial.
Feasibility of Group Problem Management Plus (PM+) to improve mental health and functioning of adults in earthquake-affected communities in Nepal.Sangraula, M., Turner, EL., Luitel, NP., et al.[2020]

References

Adapting Problem Management Plus for Implementation: Lessons Learned from Public Sector Settings Across Rwanda, Peru, Mexico and Malawi. [2022]
Problem-based self-care groups versus cognitive behavioural therapy for persons on sick leave due to common mental disorders: a randomised controlled study. [2021]
Feasibility of Group Problem Management Plus (PM+) to improve mental health and functioning of adults in earthquake-affected communities in Nepal. [2020]
Desperately seeking outcomes: quantifying the effectiveness of community mental healthcare using Health of the Nation Outcome Scales. [2020]
Clinical Case Management versus Case Management with Problem-Solving Therapy in Low-Income, Disabled Elders with Major Depression: A Randomized Clinical Trial. [2022]
The need for expanded monitoring of adverse events in behavioral health clinical trials. [2012]
Editorial: Primum non nocere - are adverse events accurately reported in studies on psychological interventions for children? [2023]
Adverse events in psychotherapy randomized controlled trials: A systematic review. [2023]
Review: Adverse event monitoring and reporting in studies of pediatric psychosocial interventions: a systematic review. [2023]
A new paradigm for mental-health quality and safety: are we ready? [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
Community-based systems of care for children's mental health services. [2005]
Clinical outcomes and cost effectiveness of two aftercare models provided by general physicians and nurses to patients with severe mental illness. [2019]
Problem Management Plus (PM+) in the management of common mental disorders in a specialized mental healthcare facility in Pakistan; study protocol for a randomized controlled trial. [2020]